Authors:
Sugden, MC
Langdown, ML
Munns, MJ
Holness, MJ
Citation: Mc. Sugden et al., Maternal glucocorticoid treatment modulates placental leptin and leptin receptor expression and materno-fetal leptin physiology during late pregnancy, and elicits hypertension associated with hyperleptinaemia in the early-growth-retarded adult offspring, EUR J ENDOC, 145(4), 2001, pp. 529-539
Citation: M. Lappas et al., Antisense oligonucleotide inhibition of type II phospholipase A(2) expression, release and activity in vitro, PLACENTA, 22(5), 2001, pp. 418-424
Citation: Mj. Munns et al., Regulation of prostaglandin F-2 alpha by the specific inhibition of secretory type II phospholipase A(2): Implications for the management of premature labour, GYNECOL OBS, 48(1), 1999, pp. 22-27
Citation: Mj. Munns et al., Reduction of human recombinant type II phospholipase A(2) and prostaglandin F-2 alpha release by microtubule depolymerizing agents, CLIN EXP PH, 26(3), 1999, pp. 230-235
Citation: Mj. Munns et al., Secretory type II PLA(2) immunoreactivity and PLA(2) enzymatic activity inhuman gestational tissues before, during and after spontaneous-onset labour at term, PLACENTA, 20(1), 1999, pp. 21-26